Related Experiment Video

Updated: Aug 18, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

Fungal phenalenones inhibit HIV-1 integrase

Kazuro Shiomi1, Ryosuke Matsui, Miki Isozaki

  • 1School of Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo 108-8641, Japan.

The Journal of Antibiotics
|April 9, 2005
PubMed

Insights

Natural compounds called phenalenones were investigated for their potential to inhibit HIV-1 integrase. Funalenone demonstrated significant anti-HIV activity with good selectivity, offering a promising avenue for antiviral drug discovery.

Area of Science:

  • Natural Product Chemistry
  • Virology
  • Medicinal Chemistry

Background:

  • Phenalenones are a class of natural compounds with diverse biological activities.
  • Human Immunodeficiency Virus (HIV) integrase is a critical target for antiviral therapies.
  • Identifying novel inhibitors of HIV-1 integrase is essential for combating HIV/AIDS.

Purpose of the Study:

  • To isolate and characterize phenalenone compounds from Penicillium sp. FKI-1463.
  • To evaluate the HIV-1 integrase inhibitory and anti-HIV activities of isolated and related natural phenalenones.
  • To assess the selectivity and cytotoxicity of these compounds as potential antiviral agents.

Main Methods:

  • Isolation of atrovenetinone methyl acetal from Penicillium sp. FKI-1463 culture broth.
  • In vitro assays to determine HIV-1 integrase inhibition (IC50 values).
  • Cell-based assays to measure anti-HIV activity (IC50 values) and cytotoxicity (IC50 values).

Main Results:

  • Atrovenetinone methyl acetal was identified as an HIV-1 integrase inhibitor with anti-HIV activity.
  • Funalenone exhibited potent HIV-1 integrase inhibition (IC50 = 10 microM).
  • Funalenone demonstrated the best selectivity, with potent anti-HIV activity (IC50 = 1.7 microM) and low cytotoxicity (IC50 = 87 microM).

Conclusions:

  • Natural phenalenones, including atrovenetinone methyl acetal and funalenone, possess significant HIV-1 integrase inhibitory and anti-HIV properties.
  • Funalenone represents a promising lead compound for the development of novel anti-HIV therapeutics due to its potent activity and favorable selectivity profile.
  • Further investigation into phenalenone derivatives could yield more effective treatments for HIV infection.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...